Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan‐Sarbecoviruses
ABSTRACT The ongoing emergence of new variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) underscores the urgent need for developing antivirals targeting both SARS‐CoV‐2 variants and related sarbecoviruses. To this end, we designed novel trispecific antibodies, Tri‐1 and Tri...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2025-05-01
|
| Reeks: | MedComm |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/mco2.70191 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
